Category: Drug Discovery
Global Drug Discovery
-
Gastrointestinal Drugs Market Covering Antacids; Antiulcerants; Antiemetics And Antinauseants; Antidiarrhoeals; Global Summary 2023
... In terms of per capita consumption, the market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and ... Read More
-
Dermatology Drugs Market Covering Acne; Dermatitis; Psoriasis; Alopecia; Global Summary 2023
... of per capita consumption, the market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ... Read More
-
Global HIV Treatment Market: Analysis By Product (Atripla, Biktarvy, Descovy, Genovya, Odefsey, Truvada, Sunlenca (Lenacapavir), Dovato, Juluca, Tivicay, Triumeq, Cabenuva, VH184, Capsid, bNAbs, Islatravir, and Generics), By Region (The US, and EU + ROW) Size and Trends with Impact of COVID-19 and Forecast up to 2030
... and Trends with Impact of COVID-19 and Forecast up to 2030 The global HIV treatment market in 2022 stood at US$22.38 billion, and is likely to reach US$25.49 billion by 2030. HIV treatment, also known ... Read More
-
Global Pulmonary Arterial Hypertension (PAH) Market: Analysis By Drug Class (Prostacyclin and Prostacyclin Analogs, Endothelin Receptor Antagonists (ERAs), sGC Stimulators, and pde-5 Inhibitors), By Type (Branded and Generic), By Route of Administration (Oral, Intravenous/ Subcutaneous, and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... and Inhalation), By Distribution Channel (Hospital Pharmacies and Clinic, Retail Pharmacies, and Online Pharmacies), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028 The global pulmonary arterial hypertension market was ... Read More
-
Cardiovascular Drugs Market Covering Anti-Hypertensive Drugs; Hypolipidemics; Anti Thrombotics; Angina Pectoris; Congestive Heart Failure; Other Drugs For Cardiovascular Diseases (Anti-Arrhythmic And Anti-Anginal Drugs); Global Summary 2023
... 2022. It was the fifth largest segment within the market accounting for 9.6%. In terms of per capita consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Post-Traumatic Stress Disorder (PTSD) Clinical trials scenario. This report provides top line data ... Read More
-
Antihyperlipidemic Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 16.0 Billion by 2028, exhibiting a growth rate (CAGR) of 4.6% during 2023-2028. Antihyperlipidemic drugs help lower serum levels of cholesterol and various lipids in the blood. They can be taken with different ... Read More
-
Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 4.0 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028. Anti-obesity drugs are intended to reduce or control weight and generally medically prescribed only in cases of morbid obesity. They ... Read More
-
Global Migraine Drugs Market - 2023-2030
... The migraine drugs market is expected to exhibit a CAGR of 12.1% during the forecast period (2023-2030), owing to the increase in the preponderance of migraine globally and the increase in awareness regarding migraine and ... Read More
-
Global Systemic Lupus Erythematosus Market - 2023-2030
... by 2030. The systemic lupus erythematosus market is expected to exhibit a CAGR of 7.3% during the forecast period (2023-2030). Systemic lupus erythematosus (SLE) is a chronic autoimmune condition that can harm the skin, joints, ... Read More
-
Next Generation Antibody Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type
... 2022 and its CAGR from 2018 to 2022, and also forecasts its market size to the end of 2028 and its CAGR from 2023 to 2028. For geography segment, regional supply, demand, major players, price ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Global Acute Myeloid Leukemia Market Size Study & Forecast, By Chemotherapy (Cytarabine, Anthracycline Drugs, Alkylating Agents, Anti-metabolites, Tyrosine Kinase Inhibitors, Hormonal Therapy, Other Chemotherapies), and Regional Analysis, 2023-2030
... at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Acute Myeloid Leukemia (AML) is a form of blood ... Read More
-
Global Periodontal Therapeutics Market - 2023-2030
... therapeutics market is expected to exhibit a CAGR of 9.2% during the forecast period (2023-2030). Adjuvant therapies following the use of antibiotics will support the trend in this market. The non-surgical treatment procedures for gum ... Read More
-
Global Cerebral Palsy Treatment Market - 2023-2030
... The global cerebral palsy treatment market is expected to exhibit a CAGR of 3.7% during the forecast period (2023-2030). The key players are adopting strategies such as partnerships, mergers, acquisitions, and regional expansion to stand ... Read More
-
Quantum Computing in Healthcare Market by Component (Hardware, Software), Deployment (0n-premises, Cloud-based), Technology (Superconducting qubits, Trapped ions), Application (Drug discovery, Genomics), End User, and Region - Global Forecast to 2028
... healthcare market is projected to reach USD 503 million by 2028 from USD 85 million in 2023, at a high CAGR of 42.5% during the forecast period. The technological advancements in quantum computing supporting various ... Read More
-
Global Scleroderma Market - 2023-2030
... exhibit a CAGR of 6.2% during the forecast period (2023-2030). The key market players are adopting various strategies such as product approvals, acquisitions, partnerships, and new launches to increase product reach and strengthen their product ... Read More
-
Global Depression Drugs Market Research Report 2023(Status and Outlook)
... at any age may suffer from depression. Depression affects the brain, so drugs that work in the brain may offer hope. Common antidepressants may help ease your symptoms, but there are many other options as ... Read More
-
Global Multiple Sclerosis Drugs Market Research Report 2023(Status and Outlook)
... This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. The Global Multiple Sclerosis Drugs Market Size ... Read More
-
Global Anti Malarial Drug Market Research Report 2023(Status and Outlook)
BSR000150927 Read More
-
Global Benign Prostatic Hyperplasia BPH Drugs Market Research Report 2023(Status and Outlook)
... in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this ... Read More
-
Global Microbiome Therapeutics Market Research Report 2023(Status and Outlook)
... microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. ... Read More
-
Global Benign Prostatic Hyperplasia BPH Drugs Market Research Report 2023(Status and Outlook)
... in puberty, when the prostate doubles in size. The second phase of growth starts around age 25 and goes on for most of the rest of a man's life. BPH most often occurs during this ... Read More
-
Global Artificial Intelligence-driven Drug Development Market Growth (Status and Outlook) 2023-2029
... it is expected to grow at a CAGR of 31.8% from 2023 to 2029. United States market for Artificial Intelligence-driven Drug Development is estimated to increase from US$ million in 2022 to US$ million by ... Read More
-
Global Invasive Fungal Infections Market: Analysis By Molecule Class (Azoles, Echinocandins, Allylamines/Pyrimidines, Polyenes and Others), By Infection Type (Candidiasis, Aspergillosis, Cryptococcus, and Other), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2028
... to 2028 Invasive fungal infections (IFIs) are serious and potentially life-threatening infections caused by fungi that invade deep tissues, organs, or the bloodstream of the human body. These infections can occur in individuals with weakened ... Read More
Research Assistance
